• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • GPs

Doctor's orders: A case study in reputational risk

  • Mikkel Stern-Peltz
  • Mikkel Stern-Peltz
  • 20 September 2016
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

After a buyout turned into a seminal event in the Nordic private equity industry, investments in the regionт€™s healthcare sector remain a controversial matter, writes Mikkel Stern-Peltz

Visit our healthcare content hub here and read the first instalments of the series

KKR and Triton's investment in Swedish private care business Carema became the catalyst for significant change in the Nordic private equity industry after 2011, when the business came under fire from the media and government after accusations of neglect and patient mistreatment.

Once the focus eventually turned to the company's private equity owners, the media, government and public outcry created arguably the brightest spotlight ever shone on the industry until that point. While what eventually became known as "the Carema Scandal" affected many changes in private equity ESG policies and transparency, it also sparked debate about private investment in sectors providing services to the state-run healthcare system.

Carema was the driver of proposals by Swedish politicians about limiting the profits of private companies providing services in the public sector – though nothing materialised and the proposals eventually dissipated

Sweden has borne the brunt of the discussion, with critical media coverage of private equity investments in private hospitals operator Capio and care provider Attendo among others. Attendo, an IK Investment Partners portfolio company, was the subject of several accusatory articles by major Swedish newspaper Svenska Dagbladet throughout the GP's ownership and leading up to the company's eventual IPO in 2015.

Before the Carema Scandal, Nordic healthcare was a universally attractive play, due to lucrative government contracts virtually guaranteeing a certain level of income. Any GP that could improve efficiency and minimise costs would be off to a good start in eking out solid profits from a company providing services to the public healthcare system.

Post-Carema, the reputational risk increased substantially, as well as the political risk. Carema was the driver of proposals by Swedish politicians about limiting the profits of private companies providing services in the public sector – though nothing materialised and the proposals eventually dissipated.

Off life support
The troubles surrounding Carema put the industry off investing in the elderly care and disabled care industries for a few years, though the verticals since became attractive again for local GPs, as the consolidation play remained.

In the past two years, the fragmented sectors have seen substantial consolidation and the process is to some degree coming to the end of its cycle in Sweden, as companies are listed or sold to trade buyers. Given the size of the companies exited, Nordic elderly and disabled care has moved into large-cap and trade territory, rather than the lower and mid-market space it historically occupied.

Given the activity in the elderly and disabled care industries in Sweden in the past five years, the sectors are likely to cool off in the next year or two, with private equity shifting its focus to other healthcare investments. In Denmark, the government ran privatisation schemes from the early 2000s that the buyout industry had hoped to benefit from. But it has since cut subsidies to these services, dropping profits for the private companies supplying them and making it a less attractive proposition for private equity.

Looking ahead, the local private equity industry is likely to focus its healthcare investments on areas such as in-home care, dental care, physiotherapy, elective and niche surgeries, as well as elderly and disabled care in countries such as Norway and Finland. While private healthcare in Finland has seen private equity involvement for years, it and Norway have historically seen less investment activity in the elderly and disabled care sectors, though demographic pressures coupled with economic tribulations are likely to strain public finances and create fertile ground for private care providers.

This year, ICG entered the fray in Finland, acquiring Finnish in-home care provider Esperi from CapMan Buyout, while Danish GP Polaris acquired Swedish plastic surgery group Akademikliniken in May.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • GPs
  • Healthcare
  • Nordics
  • Top story
  • Sweden
  • KKR
  • Triton Partners

More on GPs

IPO offers CVC chance to become multi-asset consolidator
IPO offers CVC chance to become multi-asset consolidator

Potential IPO also offers monetisation solution for founders and GP stakes investor Blue Owl

  • GPs
  • 25 August 2023
VC Profile: Possible Ventures lines up frontier tech deals halfway through fresh EUR 60m fundraise
VC Profile: Possible Ventures lines up frontier tech deals halfway through fresh EUR 60m fundraise

Germany-based pre-seed investor is set to hold a first close for its third fund in mid-September

  • GPs
  • 25 August 2023
GP Profile: Apheon builds on family roots, mulls exits and reinvestment opportunities
GP Profile: Apheon builds on family roots, mulls exits and reinvestment opportunities

Belgian GP, formerly known as Ergon, to continue to target family- and entrepreneur-owned European businesses

  • GPs
  • 18 August 2023
Kudu to step up boutique GP stake deals in Europe
Kudu to step up boutique GP stake deals in Europe

MassMutual-backed investor aims to add more infrastructure and specialised equity GPs to its portfolio

  • GPs
  • 09 August 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013